B. Braun Recalls 1,000mL Lactated Ringers Lot J4H077 Over Particulate Risk

For hospital pharmacies and patient safety teams, a voluntary recall of a ubiquitous IV fluid raises immediate operational questions: Is lot J4H077 in our inventory, which patients received it, and what surveillance is needed? B. Braun's recall of its 1,000 mL Excel Lactated Ringers Injection due to particulate matter puts patient safety and recall readiness at the center.

B. Braun Medical Inc. announced a voluntary North American recall of a single lot of its Excel Lactated Ringers Injection, 1,000 mL product on August 19, 2026 due to the presence of particulate matter. The recall, posted on the U.S. FDA website, covers lot J4H077, which was distributed to hospital-level facilities across the United States and Canada between August 29, 2024 and September 30, 2024, and carries an expiration date of November 30, 2026. The contamination was identified primarily as cellulose cotton fibers, with additional particles characterized as cellulose wood fiber and polystyrene.

“

For hospital pharmacies and patient safety teams, a voluntary recall of a ubiquitous IV fluid raises immediate operational questions: Is lot J4H077 in our inventory, which patients received it, and what surveillance is needed?

This is not a routine packaging defect. Particulate matter in an intravenous solution can travel directly into the bloodstream, creating a risk of mechanical and inflammatory injury. B. Braun's recall notice states that use of the defective product has a reasonable probability of causing pulmonary emboli, occlusions of other blood vessels that can lead to tissue death and organ damage, and phlebitis. Systemically, foreign particles infused intravenously can activate the immune system, contribute to organ dysfunction, and cause hemolysis. The product is used for hydration and electrolyte replacement in adult, pediatric, and neonatal patients, which broadens the clinical concern because smaller and more fragile patients may be especially vulnerable to embolic or inflammatory complications.

The contaminant profile is a meaningful clue for quality investigators. Cellulose cotton fibers, cellulose wood fiber, and polystyrene are not typical formulation ingredients. Their presence suggests contamination may have entered through raw materials, filtration media, packaging components, or processing equipment. Polystyrene, for example, is widely used in plastic labware, packaging trays, and some filter housings. Cotton and wood cellulose often appear in wipes, filters, and paper-based materials. The fact that three distinct particle types were identified implies either multiple contamination sources or a broader breakdown in particulate control. For an injectable product intended for direct vascular administration, this kind of foreign material is exactly what current good manufacturing practice and visible and subvisible particle testing are designed to prevent.

From a supply chain and recall execution standpoint, the timing matters. The lot was distributed over a one-month window in late summer 2024. With an expiration date of November 30, 2026, much of the lot could still theoretically be in inventory, on pharmacy shelves, or in use if not successfully quarantined. B. Braun says it is notifying distributors and customers, but hospital pharmacies will still need to actively check their stock against lot J4H077. Because Lactated Ringers is a high-use resuscitation and maintenance fluid, even a single-lot recall can create localized inventory gaps if facilities must immediately pull all units and seek replacement product.